Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-31
SponsorNorthwestern University

About this trial

This study is testing three ways to deliver Early Intervention (EI) services for toddlers with developmental disabilities (DD).

Children enrolled in EI speech therapy will receive one of three approaches:

1. Therapist Delivered EI: For 28 weeks, the child's speech therapist will work directly with the child to support their communication. 2. Caregiver Coaching EI: For 28 weeks, the child's speech therapist will coach the caregiver on how to support their child's communication. 3. Combined EI Approach + Parent-Led Education Program: For 14 weeks, the caregiver will take part in a parent-led education program while the speech therapist works directly with the child to support their communication. During the next 14 weeks, the speech therapist will coach the caregiver on how to support their child's communication.

The goal of this study is to identify which approaches are most effective so that all families can benefit fully from EI services.

Eligibility criteria

Qualifiers

At least 12 months old

At least 7 months of Early Intervention (EI) service eligibility remaining

Enrolled in the Illinois EI system and is new to the speech-language pathologist's (SLP's) caseload (i.e., no prior EI speech-language therapy experience with the SLP)

Plans to receive one hour of speech-language therapy per week in the home or in a private space outside of the home

Disqualifiers

The child's parent, legal guardian, or other family member

Self-identifies as Black, Latine (Hispanic), or white

Available to participate in weekly EI sessions and study assessments.

Younger than 18 years old at enrollment

Trial design

Treatments tested in this trial

  • Therapist-Delivered Early Intervention Approach
  • Caregiver Coaching Early Intervention Approach
  • Parents Taking Action

Treatment groups

1,269 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Northwestern University

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator